A Study of Escalating Doses of Romidepsin in Association With CHOP in the Treatment of Peripheral T-Cell Lymphomas
Clinical trial NCT01280526 · COMPLETED
Trial details
- NCT number
- NCT01280526
- Sponsor
- The Lymphoma Academic Research Organisation
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-01
- Primary completion
- 2012-11-01
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.